Growth Metrics

Neogenomics (NEO) Other Non-Current Assets (2016 - 2026)

Neogenomics filings provide 16 years of Other Non-Current Assets readings, the most recent being $9.6 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 59.73% to $9.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $9.6 million, a 59.73% increase, with the full-year FY2025 number at $9.4 million, up 59.6% from a year prior.
  • Other Non-Current Assets hit $9.6 million in Q1 2026 for Neogenomics, up from $9.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $9.6 million in Q1 2026 to a low of $4.1 million in Q2 2024.
  • Median Other Non-Current Assets over the past 5 years was $5.9 million (2024), compared with a mean of $6.2 million.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 40.64% in 2022 and later soared 74.9% in 2025.
  • Neogenomics' Other Non-Current Assets stood at $5.1 million in 2022, then fell by 7.18% to $4.7 million in 2023, then rose by 24.12% to $5.9 million in 2024, then surged by 59.6% to $9.4 million in 2025, then rose by 2.14% to $9.6 million in 2026.
  • The last three reported values for Other Non-Current Assets were $9.6 million (Q1 2026), $9.4 million (Q4 2025), and $8.2 million (Q3 2025) per Business Quant data.